Assessing bleeding risk in 18 children with Osteogenesis imperfecta

Affiliations

• ¹ Department of Clinical Biochemistry, Necker Enfants Malades Hospital, AP-HP, Paris, France.
• ² INSERM UMR_S1140, Faculty of Pharmacy, Paris Descartes University, Paris, France.
• ³ Department of Haematology, Reference Centre for Platelet Disorders, Armand Trousseau Hospital, AP-HP, Paris, France.
• ⁴ Department of Haematology, Haemophilia Care Centre, Necker Enfants Malades Hospital, APHP, Paris, France.
• ⁵ Department of Haematology, Necker Enfants Malades Hospital, AP-HP, Paris, France.
• ⁶ INSERM UMR_S1176, Paris-Sud University, Paris-Saclay University, le Kremlin-Bicêtre, France.
• ⁷ Department of Paediatric Physical Therapy and Rehabilitation, Armand Trousseau Hospital, AP-HP, Paris, France.
• ⁸ Department of Clinical Biochemistry, Armand Trousseau Hospital, AP-HP, Paris, France.
• ⁹ Department of Medical Genetics, Necker Enfants Malades Hospital, AP-HP, Paris, France.
• ¹⁰ INSERM U1163, Imagine Institute, Paris Descartes University, Paris, France.
• ¹¹ INSERM UMR_S1139, Faculty of Pharmacy, Paris Descartes University, Paris, France.